ARGX लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

खरीदें 108 min ago

@ $449.41

जारी किया गया: 26 Jun 2024 @ 19:05

वापसी: -0.45%

पिछला सिग्नल: Jun 24 - 19:01

पिछला सिग्नल: बेचें

वापसी: 2.83 %

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:54):
Our systems believe the stock currently is undervalued by 0.06% compare to its pairs and should correct upwards.

Stats
आज की मात्रा	126 486
औसत मात्रा	272 396
बाजार मूल्य	26.59B
EPS	$-1.040 ( Q1 \| 2024-03-21 )
अगली कमाई की तारीख	( $-0.860 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-78.62 (Sector) 42.63 (Industry) 24.32
ATR14	$11.89 (2.66%)

AADI -2.37%

ABCL 1.65%

ABCM 0.04%

ABEO -2.84%

ABIO -0.98%

ABOS 0.93%

ABSI 3.06%

ABUS -2.62%

ABVX -3.53%

ACAD -0.80%

ACER -17.95%

ACET -3.42%

ACGN 1.29%

ACHL -4.15%

ACHV -1.73%

ACIU -0.50%

ACLX -0.20%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.97%

ADGI 0.87%

ADIL 0.54%

ADMA -2.54%

ADPT -0.30%

ADTX -3.47%

ADVM -3.18%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -2.10%

AGEN -0.81%

AGIO -1.88%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.14%

AKRO -2.79%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.41%

ALEC -4.13%

ALGS -2.41%

ALKS -0.21%

ALLK -8.90%

ALLO -6.67%

ALLR -3.70%

ALNA 3.16%

ALNY 1.57%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.45%

ALVR 0.92%

ALXN 0.00%

ALXO -10.81%

ALZN 5.07%

AMRN 0.26%

AMTI -3.13%

ANAB 0.42%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.33%

ANPC -3.15%

APGE -0.96%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.10%

APLT -4.17%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.99%

ARDS -14.23%

ARDX -0.83%

ARGX -0.93%

ARNA 0.00%

ARPO -0.90%

ARQT -0.31%

ARTL -2.50%

ARTLW 0.00%

ARVN 4.95%

ARWR -1.82%

ASLN -3.18%

ASMB -3.70%

ASND -1.27%

ATAI -1.11%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.98%

ATOS 4.85%

ATRA -2.88%

ATXI 1.93%

ATXS -1.05%

AUPH -1.17%

AURA -0.15%

AUTL -1.87%

AVBP -2.79%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -5.17%

AVTX -1.25%

AVXL -2.84%

AXLA 0.00%

AXSM -1.67%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.73%

BCAB 3.27%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.32%

BCTX 8.12%

BCTXW -20.05%

BCYC 0.64%

BDRX -6.62%

BDTX -0.85%

BEAM -0.08%

BFRA -2.91%

BGNE -2.19%

BIOR -1.72%

BIVI 0.56%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.80%

BMEA -9.63%

BMRN 0.38%

BNOX -2.22%

BNTC -2.11%

BNTX -1.16%

BOLD -8.80%

BOLT -0.19%

BPMC -1.26%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.38%

BTAI 24.62%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.76%

CADL -0.53%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.85%

CARM 11.74%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.99%

CCCC -5.20%

CCXI 0.00%

CDAK 0.00%

CDIO -3.09%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC -0.41%

CDXS 4.31%

CELC -3.43%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.88%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.62%

CGEN -3.31%

CGON -0.13%

CGTX -4.55%

CHMA -6.00%

CHRS -0.47%

CINC 0.00%

CING 0.67%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.43%

CLNNW 0.00%

CLRB 6.63%

CLSD -2.90%

CLSN -0.68%

CLVS 0.00%

CMMB -1.96%

CMND 3.63%

CMPI 0.00%

CMPX -10.42%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.49%

CNST 0.00%

CNTA -0.67%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -3.14%

CORT 2.01%

COYA -1.46%

CPRX -0.46%

CRBP -2.11%

CRBU -4.83%

CRDF -2.21%

CRGX 1.34%

CRIS -0.38%

CRNX -5.93%

CRSP 0.94%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -2.50%

CTNM -3.66%

CTXR 1.28%

CUE 3.60%

CVAC -1.98%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 8.81%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.98%

CYTO -2.73%

DARE 6.54%

DAWN 0.30%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 28.32%

DNLI -1.99%

DNTH -6.31%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.52%

DTIL 0.89%

DYAI 9.68%

EARS -1.77%

EDIT -2.46%

EDSA -1.00%

EFTR 7.54%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -5.39%

ELOX 7.69%

ELTX -0.88%

ELVN -4.52%

ELYM 1.12%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.24%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.38%

ETON -0.30%

ETTX 0.00%

EVAX -2.14%

EVGN 6.35%

EVLO 0.00%

EWTX -0.03%

EXAI -0.43%

EXEL -0.22%

EYEG -0.69%

EYEN 1.54%

EYPT 0.12%

FATE -8.06%

FBIO 0.59%

FBIOP 0.92%

FBLG -18.00%

FBRX -0.04%

FDMT -4.72%

FENC -1.29%

FGEN -5.11%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.38%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.69%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.50%

GANX -1.42%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.54%

GHRS -2.85%

GLMD 0.31%

GLPG -2.30%

GLSI 2.80%

GLTO -1.20%

GLUE -1.58%

GLYC -9.50%

GMAB -0.50%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 0.89%

GNPX 0.98%

GNTA 3.94%

GOSS -7.84%

GOVX 3.64%

GOVXW -49.04%

GPCR -7.13%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.14%

GRTX 0.00%

GTHX 0.00%

GUTS -5.31%

GXGXW 41.67%

GYRE -6.02%

HALO -0.76%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.56%

HRMY 1.10%

HRTX 1.80%

HSTO 0.00%

HUMA 1.32%

HUMAW -0.01%

IBRX -3.99%

ICCC 0.22%

ICPT 0.21%

ICU 16.67%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.44%

IFRX -2.66%

IGMS -0.11%

IKNA 0.60%

IKT 1.42%

IMAB -0.87%

IMCR -2.61%

IMGN 0.02%

IMGO 0.00%

IMMP 4.58%

IMMX -7.76%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.84%

IMTX -1.75%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.50%

INAB 0.59%

INBX 0.46%

INCY -0.84%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.80%

INO -1.95%

INSM -0.71%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.02%

IONS -0.23%

IOVA -2.37%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.54%

ISEE 0.38%

ITOS -1.57%

ITRM 1.67%

IVA 6.96%

IVVD -4.13%

JAGX 0.28%

JANX -4.08%

JAZZ -0.56%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.99%

KDNY 0.22%

KMPH -0.34%

KNSA -2.95%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -9.25%

KRTX 0.03%

KRYS -0.86%

KTRA 16.13%

KTTA 8.16%

KTTAW 0.92%

KURA -1.91%

KYMR -2.05%

KYTX -3.62%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.01%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.86%

LENZ -4.07%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -8.53%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.52%

LPCN -5.03%

LPTX -1.65%

LQDA -0.33%

LRMR -1.92%

LSTA -4.06%

LTRN 0.25%

LUMO -1.32%

LVTX 0.00%

LXEO -4.86%

LXRX -2.06%

LYEL -35.63%

LYRA 3.29%

MACK 0.10%

MBIO -8.94%

MBRX -1.74%

MCRB 1.62%

MDGL -2.31%

MDNA -13.16%

MDWD 0.10%

MDXG -2.50%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.61%

MGX -2.68%

MIRM -1.42%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -1.11%

MLYS -5.75%

MNKD -1.05%

MNMD 0.14%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -3.34%

MREO -4.14%

MRKR 2.68%

MRNA -4.92%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.25%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 8.38%

NAMS 1.73%

NAMSW 0.43%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.40%

NKGN 5.88%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.57%

NLSP -2.88%

NLSPW 26.67%

NMRA -0.57%

NMTR -42.97%

NOVN -24.84%

NRBO 11.52%

NRIX -0.89%

NRSN -3.63%

NRSNW 0.00%

NRXP -5.72%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.29%

NTRBW -31.07%

NUVL -1.97%

NVAX -1.21%

NVCT 3.94%

NVIV -34.28%

NXTC -3.24%

NYMX -0.05%

OABI 0.33%

OABIW -10.06%

OBIO -3.21%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.02%

OCUL -1.90%

OCUP 1.64%

ODT -4.27%

OKYO 1.51%

OLMA -5.63%

OMER -0.77%

OMGA 6.25%

ONCO 7.71%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.00%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 1.03%

ORGS -4.53%

ORIC -3.56%

ORMP 15.18%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.31%

PBLA -7.50%

PBM -7.29%

PBYI 1.01%

PCSA 0.00%

PCVX -0.23%

PDSB -0.95%

PEPG 1.55%

PGEN -3.59%

PHAR 1.51%

PHAS 0.00%

PHAT -1.26%

PHIO -4.96%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.64%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT 0.28%

PRAX 0.60%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.89%

PRQR -0.01%

PRTA -2.34%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.16%

PTCT -0.31%

PTE -0.82%

PTGX -1.73%

PTIXW -49.04%

PULM 2.62%

PXMD 0.00%

PYPD 0.07%

PYXS 4.09%

QLGN -3.72%

QNCX 5.67%

QNRX 0.37%

QSI -11.62%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -3.22%

RARE 1.23%

RCKT -8.09%

REGN -0.74%

RENB -3.42%

REPL -3.00%

RETA 0.02%

REUN -0.89%

REVB -0.92%

REVBU 3.46%

REVBW 4.38%

RGLS -4.72%

RGNX -5.28%

RIGL -3.28%

RLAY -4.60%

RLMD 0.33%

RLYB 0.00%

RNA -0.41%

RNAC -5.65%

RNAZ -0.11%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.30%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.27%

RVMDW -30.00%

RVNC 1.91%

RVPH -1.02%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.52%

RYTM -6.24%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.47%

SANA -3.87%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -1.01%

SCPS 0.00%

SEEL -4.09%

SEER -0.44%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.01%

SGMT -1.67%

SGTX -2.56%

SIOX 22.63%

SLDB -4.40%

SLGL 4.00%

SLN -4.21%

SLNO -2.39%

SLRX 5.91%

SLS -2.99%

SMMT -2.74%

SNDX 0.61%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -4.17%

SPRO 0.04%

SRNE -31.19%

SRPT -1.23%

SRRA 0.00%

SRRK -2.29%

SRZN -2.45%

STAB 0.00%

STOK -4.89%

STRO -2.74%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.16%

SWTX -0.03%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -6.19%

TARS 0.08%

TBPH 0.36%

TCBP 0.00%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.67%

TECH -0.14%

TENX -1.27%

TERN -6.62%

TFFP -3.05%

TGTX -3.00%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.59%

TNXP -5.34%

TNYA -8.58%

TPST 2.52%

TRDA -3.86%

TRVI 0.77%

TRVN 5.02%

TSHA -24.34%

TSVT -2.40%

TTNP -9.27%

TVTX 0.31%

TYRA -8.19%

UBX -0.96%

UNCY -3.39%

URGN -1.97%

UTHR -0.45%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL 0.29%

VCNX 10.35%

VCYT -1.23%

VERA -2.78%

VERU 0.72%

VERV -2.58%

VIGL 6.18%

VINC 1.62%

VIR 0.84%

VIRI -1.61%

VIRX 3.33%

VKTX -1.02%

VLON -13.04%

VNDA -2.36%

VOR -1.63%

VRCA 0.50%

VRDN -3.92%

VRNA -1.20%

VRPX 0.38%

VRTX 0.08%

VSTM -3.40%

VTGN -1.81%

VTVT -2.97%

VTYX -0.42%

VXRT -2.67%

VYGR -1.92%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.71%

XBIO 0.93%

XBIT 0.83%

XCUR 3.61%

XENE -3.05%

XERS 2.14%

XFOR 3.73%

XLO 4.43%

XLRN 0.00%

XNCR 0.16%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -9.85%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.19%

ZNTL -2.86%

ZSAN 0.00%

सहसंबंध (AI algo v.1.1b): Undervalued: 0.06% $447.58 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.86 (strong)

छोटा: -0.82 (strong negative)

Signal:(40) Neutral

argenx SE सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
OZEM	1

10 सबसे अधिक नकारात्मक सहसंबंध
RFAIU	-0.896
ERNZ	-0.895
INDH	-0.87

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

argenx SE सहसंबंध - मुद्रा/वस्त्र

-0.38
( neutral )

-0.53
( weak negative )

-0.33
( neutral )

-0.20
( neutral )

-0.32
( neutral )

0.60
( weak )

argenx SE वित्तीय

Annual	2023
राजस्व:	$1.23B
सकल लाभ:	$1.11B (90.39 %)
EPS:	$-5.16

FY	2023
राजस्व:	$1.23B
सकल लाभ:	$1.11B (90.39 %)
EPS:	$-5.16

FY	2022
राजस्व:	$410.75M
सकल लाभ:	$381.32M (92.83 %)
EPS:	$-13.05

FY	2021
राजस्व:	$497.28M
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-7.99

Financial Reports:

No articles found.

argenx SE Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

argenx SE

argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelinating polyneuropathy in Phase III clinical trials; bullous pemphigoid and idiopathic inflammatory myopathy in Phase II/III clinical trials; and ENHANZE SC in Pre-clinical study. The company is also developing immunology innovation programs, including cusatuzumab for hematological cancer, as well as high risk MDS; ARGX-119, an antibody that targets muscle-specific tyrosine kinase stage; ARGX-117 for severe autoimmune indications; ARGX-118 for airway inflammation; and ARGX-120 to treat autoimmune diseases. In addition, its partnered product candidates include ARGX-115 for the treatment of cancer; ARGX-112 to treat interleukin-22 receptor; and ARGX-114, an antibody directed against the MET receptor. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. argenx SE was incorporated in 2008 and is based in Breda, the Netherlands.